Josi: Expand access to non-opioid pain treatment
Passing the Alternatives to PAIN Act would be an excellent way for Trump to uphold his promise to “Make America Healthy Again ...
Jacksonville Journal-Courier on MSN12 小时Opinion
Commentary: Expand access to non-opioid pain treatments — Christian Josi
The opioid crisis has touched nearly every demographic in our society. One area that doesn’t get enough attention is the toll ...
Josi: Expand access to non-opioid pain treatments
The first major legislative win for this issue came in 2022 when the NO PAIN Act was signed into law. By providing separate ...
Vertex is hoping for 'historic' non-opioid painkiller approval. It might not be a ...
This week, the FDA will decide whether to approve Vertex Pharmaceuticals' non-opioid painkiller. Vertex believes pain could ...
FierceBiotech4 小时
Tris builds clinical case for opioid alternative by showing its pain drug is less likely to ...
Having shown last week that its opioid alternative can reduce post-surgery pain, Tris Pharma is back with another slice of ...
Billed as nonaddictive, new pain pill could soon win FDA approval
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove safe and effective for chronic pain.
Racial disparities in opioid prescriptions persist despite socioeconomic factors
Non-white communities had significantly less access to opioid medications commonly prescribed for moderate to severe pain ...
Charleston Gazette-Mail5 天Opinion
Christian Josi: Expanding access to non-opioid pain management (Opinion)
Perhaps no issue has devastated our public health more over the last 25 years than the opioid crisis. Thankfully, there are ...
pharmaphorum5 天
Tris cues up filing for non-opioid pain drug on phase 3 win
The new data comes from the phase 3 ALLEVIATE-1 trial, which compared cebranopadol to placebo for the management of ...